| Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas R Pezzilli, A Andriulli, C Bassi, G Balzano, M Cantore, G Delle Fave, ... World Journal of Gastroenterology: WJG 19 (44), 7930, 2013 | 141 | 2013 |
| Pet therapy effects on oncological day hospital patients undergoing chemotherapy treatment M Orlandi, K Trangeled, A Mambrini, M Tagliani, A Ferrarini, L Zanetti, ... Anticancer research 27 (6C), 4301-4303, 2007 | 139 | 2007 |
| Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer E Bajetta, I Floriani, M Di Bartolomeo, R Labianca, A Falcone, ... Annals of oncology 25 (7), 1373-1378, 2014 | 107 | 2014 |
| Combined irinotecan and oxaliplatin in patients with advanced pre-treated pancreatic cancer M Cantore, C Rabbi, G Fiorentini, C Oliani, D Zamagni, C Iacono, ... Oncology 67 (2), 93-97, 2004 | 105 | 2004 |
| Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5‐fluorouracil in patients with unresectable biliary tract tumors M Cantore, A Mambrini, G Fiorentini, C Rabbi, D Zamagni, R Caudana, ... Cancer 103 (7), 1402-1407, 2005 | 93 | 2005 |
| Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma M Cantore, R Girelli, A Mambrini, I Frigerio, G Boz, R Salvia, A Giardino, ... Journal of British Surgery 99 (8), 1083-1088, 2012 | 80 | 2012 |
| FOLFOX or CAPOX in stage II to III colon cancer: efficacy results of the Italian three or six colon adjuvant trial A Sobrero, S Lonardi, G Rosati, M Di Bartolomeo, M Ronzoni, N Pella, ... Journal of Clinical Oncology 36 (15), 1478-1485, 2018 | 76 | 2018 |
| GemOx (gemcitabine+ oxaliplatin) versus Gem (gemcitabine) in non resectable pancreatic adenocarcinoma: Final results of the GERCOR/GISCAD Intergroup Phase III C Louvet, R Labianca, P Hammel, G Lledo, F De Braud, T Andre, ... Journal of Clinical Oncology 22 (14_suppl), 4008-4008, 2004 | 70 | 2004 |
| Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study R Buzzoni, S Pusceddu, E Bajetta, F De Braud, M Platania, C Iannacone, ... Annals of Oncology 25 (8), 1597-1603, 2014 | 67 | 2014 |
| Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial S Lonardi, A Sobrero, G Rosati, M Di Bartolomeo, M Ronzoni, G Aprile, ... Annals of Oncology 27 (11), 2074-2081, 2016 | 66 | 2016 |
| TERT gene harbors multiple variants associated with pancreatic cancer susceptibility D Campa, C Rizzato, R Stolzenberg‐Solomon, P Pacetti, P Vodicka, ... International journal of cancer 137 (9), 2175-2183, 2015 | 66 | 2015 |
| Intra-arterial hepatic carboplatin-based chemotherapy for ocular melanoma metastatic to the liver. Report of a phase II study M Cantore, G Fiorentini, E Aitini, B Davitti, G Cavazzini, C Rabbi, ... Tumori Journal 80 (1), 37-39, 1994 | 60 | 1994 |
| Triple approach strategy for patients with locally advanced pancreatic carcinoma A Giardino, R Girelli, I Frigerio, P Regi, M Cantore, A Alessandra, ... Hpb 15 (8), 623-627, 2013 | 59 | 2013 |
| Use and perceived benefits of complementary therapies by cancer patients receiving conventional treatment in Italy A Bonacchi, L Fazzi, A Toccafondi, M Cantore, A Mambrini, MG Muraca, ... Journal of pain and symptom management 47 (1), 26-34, 2014 | 57 | 2014 |
| Intra-arterial chemotherapy for unresectable pancreatic cancer M Cantore, P Pederzoli, G Cornalba, G Fiorentini, S Guadagni, ... Annals of oncology 11 (5), 569-574, 2000 | 56 | 2000 |
| Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy E Giovannetti, P Pacetti, M Reni, LG Leon, A Mambrini, E Vasile, ... Pharmacogenomics 12 (12), 1641-1652, 2011 | 55 | 2011 |
| Chemotherapy in the last 30 days of life of advanced cancer patients P Pacetti, G Paganini, M Orlandi, A Mambrini, MC Pennucci, A Del Freo, ... Supportive Care in Cancer 23, 3277-3280, 2015 | 54 | 2015 |
| Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium D Campa, C Rizzato, G Capurso, N Giese, N Funel, W Greenhalf, ... Digestive and liver disease 45 (2), 95-99, 2013 | 54 | 2013 |
| TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive … G Fiorentini, C Aliberti, G Benea, F Montagnani, A Mambrini, PL Ballardini, ... Hepato-gastroenterology 55 (88), 2077-2082, 2008 | 51 | 2008 |
| Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase II clinical study G Fiorentini, S Rossi, P Dentico, P Bernardeschi, A Calcinai, F Bonechi, ... Tumori Journal 89 (4), 382-384, 2003 | 49 | 2003 |
